More PRNewswire
View Older Stories View Newer Stories-
Pye-Barker Fire & Safety Announces Minority Investments from ADIA and GIC to Fuel New Growth
-
2024 Marks Breakout Year for China's ETF Market with Unprecedented Growth
-
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
-
New Kearney GBPC report, World in flux, highlights five wildcards that could dramatically shape the global outlook and the operating environment for business over the next five years
-
Keeper Security's Paul Aronhime Named a Top Public Sector Leader to Watch in 2025
-
HFSA and Elsevier Announce Inaugural Editor-in-Chief of New Journal of Cardiac Failure-Intersections
-
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
-
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
-
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Conduct Investor Workshop at the Mar-A-Lago Club
-
Is Spring Break 2025 the Most Expensive Yet? Here's What You Need to Know
-
Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases
-
Nano Labs Subsidiary Nano bit and BitFi Enter Strategic Partnership to Revolutionize Bitcoin Asset Management
-
Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress
-
Triller Saves Creators' TikTok Content Ahead of Ban
-
Breaking Stereotypes: New 3Fun Survey Reveals Media's Missteps in Polyamory Representation
-
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
-
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)
-
KORE Recognized for Connected Vehicle Innovation in 2025 IoT Breakthrough Awards Program
-
Verismo Therapeutics Announces First Patient Infused in Phase 1 CELESTIAL-301 Clinical Trial of SynKIR™-310
-
Diakonos Oncology to Present at Biotech Showcase 2025
-
BofA's Consumer Investments Surpasses $500 Billion in Assets as Clients Choose High-Tech, High Touch Approach to Managing Finances
-
Trumid Reports December and Full Year 2024 Trading Highlights
-
Barington Capital Group Files Definitive Proxy Statement for Matthews International's 2025 Annual Meeting
-
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter
-
ESA Strengthens Leadership in Virginia's Community Solar Market with Key 2024 Milestones
-
Bank of Montreal Enters into Automatic Securities Purchase Plan
-
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Receives FDA Clearance for Pediatric Use, Offering a Comfortable, Child-Friendly Solution for Young Patients
-
Wealth Enhancement Announces Acquisition of Danison & Associates, Inc., an Independent RIA with Over $82 Million in Client Assets
-
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
-
Regal Rexnord Corporation to Host Fourth Quarter 2024 Earnings Conference Call on Thursday, February 6, 2025
-
Powerfleet to Present at the 27th Annual Needham Growth Conference
-
Serna Bio Announces Scientific Advisory Board
-
Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing
-
Immorta Bio to Present New Data on SenoVax™ and StemCell Revivify™ at Biotech Showcase 2025
-
Cmbio® Acquires Eagle Genomics' Assets to Enhance Multi-Omics Software and AI/ML capabilities of its Digital Biology Platform.
-
A Blockbuster Year for Concierge Medicine: Specialdocs Reports a Record 26 Physician-Clients Launched Practices in 2024
-
General Counsel Åsa Thunman to leave Sandvik
-
Spectral Capital Welcomes Aaron Christensen as Chief Revenue Officer to Lead Global Expansion of Vogon Cloud Solutions
-
Net Lease Office Properties Announces Sales of Five Office Properties Totaling $43 Million
-
Alphyn to Present at Upcoming Investor Conferences
-
Opera to Participate in Upcoming Investor Conference
-
Global Times: Nearly 80% of foreign respondents show confidence in China's development prospect in first survey on China's international image
-
FINAL DAYS OF DSF: LAST CHANCE TO EXPERIENCE THE EPIC 30TH EDITION IN ITS CLOSING WEEKEND
-
Global Competition Launches to Drug 'Undruggable' Cancer Target
-
Five Star Franchising brands named 2025 Top Franchises by Franchise Business Review
-
Aircastle Announces Third Quarter 2024 Results
-
Marengo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
-
Empowering the Next Generation: Aurora Announces German Internship Program
-
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
